Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
biogen
boston top stories
bristol-myers squibb
celgene
clinical trials
eli lilly
gilead sciences
ipo
m&a
What
bio
days
roundup
acquisitions
airport
announced
annual
apocalypse
august
beds
biotech
busy
celgene
ceo
collabs
covid
daniel
deal
decisions
devices
drugs
fallout
fda
gilead
gilead’s
gone
help
home
introduce
ipo
j.p
jpm
legacy
medicines
month
news
nods
notes
opioid
o’day
Language
unset
Current search:
allergan
×
fda
×
novartis
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
